Indication
squamous cell carcinoma of the sinonasal tract
1 clinical trial
1 product
Clinical trial
Birinapant and Intensity Modulated Re-Irradiation Therapy (IMRRT) for Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC)Status: Terminated, Estimated PCD: 2023-11-15
Product
Birinapant